• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Patients with acute coronary symptoms exposed to benzodiazepines have four-fold relative risk of developing posttraumatic stress disorder

byJack LennonandAlex Chan
January 19, 2021
in Cardiology, Psychiatry
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

Associations remain inconclusive between religiosity and spirituality on medication adherence in cardiovascular disease

2 Minute Medicine Rewind, May 16

2 Minute Medicine Rewind April 9, 2022

1. Patients with acute coronary symptoms exposed to benzodiazepines had four-fold relative risk of developing posttraumatic stress disorder, adjusting for symptoms of acute stress disorder.

Evidence Rating Level: 2 (Good)

Morphine and benzodiazepines are often provided during acute coronary syndromes (ACSs) for pain and anxiety, with beta-blockers also serving to reduce pain. However, benzodiazepines are known to increase the risk of posttraumatic stress symptoms (PTSS) during other traumas, suggesting that they may act similarly in ACS. This retrospective cohort study recruited 154 participants (M [SD] age = 58.7 [10.9] years, 15.6% female) from the Myocardial Infarction-Stress Prevention Intervention (MI-SPRINT) randomized controlled trial with a verified ACS, extracting baseline demographic, clinical, and psychological variables from patient records. Posttraumatic stress symptoms were assessed via the Clinician-Administered PTSD Scale (CAPS). PTSS were assessed three months following ACS. Approximately 37.7% of patients were exposed to benzodiazepines during ACS, while 72.1% were exposed to morphine and 88.3% to beta-blockers. Only 7.1% were provided antidepressant medication. Of the 154 participants, 11.7% (18) participants developed PTSD. Benzodiazepine use was significantly associated with CAPS total severity score after adjusting for all covariates (unstandardized coefficient B [SE] = 0.589 [0.274]; partial r = 0.18, p = 0.032). Benzodiazepine use was also associated with the re-experiencing score of the CAPS, which includes nightmares (B [SD] = 0.433 [0.217]; partial r = 0.17, p = 0.047). Those who were exposed to benzodiazepines demonstrated nearly four-times greater relative risk of developing PTSD, adjusting for symptoms of acute stress disorder (OR = 3.75, 95% CI 1.31 to 10.77). No predictive value was yielded from morphine, beta-blockers, or antidepressants. Overall, this study suggests that benzodiazepines, while effective in the short-term, may increase the risk of developing PTSD and related symptoms in those with ACS.

Click to read the study in JAHA

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiologypsychiatryptsd
Previous Post

#VisualAbstract: Every-other-day dosing of oral rimegepant is effective for preventive treatment of migraines

Next Post

Early, short-term tranexamic acid does not improve clinical outcomes at 6 months in patients with subarachnoid hemorrhage 

RelatedReports

Cardiology

Associations remain inconclusive between religiosity and spirituality on medication adherence in cardiovascular disease

May 16, 2022
Image-guided percutaneous drainage of pericardial effusions is safe and effective
Weekly Rewinds

2 Minute Medicine Rewind, May 16

May 16, 2022
Weekly Rewinds

2 Minute Medicine Rewind April 9, 2022

May 9, 2022
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Weekly Rewinds

2 Minute Medicine Rewind May 2, 2022

May 2, 2022
Next Post
2 Minute Medicine Rewind June 1 – June 7, 2015

Early, short-term tranexamic acid does not improve clinical outcomes at 6 months in patients with subarachnoid hemorrhage 

#VisualAbstract: Every-other-day dosing of oral rimegepant is effective for preventive treatment of migraines

#VisualAbstract: Lower dose of ketorolac found to be non-inferior for pain management of renal colic

SARS-CoV-2 detected on various surroundings of asymptomatic COVID-19 positive infant

Potential impact of individual exposure histories to endemic human coronaviruses on age-dependent severity of COVID-19

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Long-acting cabotegravir significantly decreases incidence of HIV compared to daily oral tenofovir
  • Oral methylprednisolone may reduce risk of progressive renal failure in patients with IgA nephropathy: TESTING Trial
  • #VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.